Latest News and Press Releases
Want to stay updated on the latest news?
-
Population modelling study published in Kidney International ReportsAnalysis of over 1.2 million genomes from five international databases predicts a substantial, previously underdiagnosed adult...
-
Siren Biotechnology Publishes Foundational AAV Immuno-Gene Therapy Data and Announces Presentations at ASGCT 2026
-
BOSTON, April 16, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana”), a biotechnology company developing its lead candidate, intranasal foralumab, a fully human,...
-
A single-dose of Trogenix’s proprietary Synthetic Super-Enhancers achieved complete tumour elimination in 83% of treated cases with no toxicity over 11 months and no tumour recurrence in a brain...
-
Microbot Medical® Strengthens LIBERTY®’s Position with Publication of its ACCESS PVI Pivotal Study in Leading Peer-Reviewed Medical Journal
-
UNION, N.J., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Kean University President Lamont O. Repollet, Ed.D., has released Leadership by Design: Winning Hearts, Building Your Brand, and Achieving Success, a...
-
MIAMI, Jan. 26, 2026 (GLOBE NEWSWIRE) -- As more than 1,500 plaintiff and criminal defense attorneys gather in Miami Beach this week for the Trial Lawyers Summit, a fundamental shift is underway in...
-
BOSTON, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana”), a biotechnology company developing its lead candidate, intranasal foralumab, a fully human, anti-CD3...
-
St. Petersburg, FL, Nov. 26, 2025 (GLOBE NEWSWIRE) -- November 26, 2025 – Following the global success of Kickstarter phenomenon and Amazon bestseller The Book: The Ultimate Guide to Rebuilding...
-
CRANBURY, N.J., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Ophthalmology Times®, a trusted clinical publication specialized in eye care, is proud to celebrate five decades of excellence in advancing...